Insurance-backed Oncology Program Eases Patient Symptoms

Insurance-backed Oncology Program Eases Patient Symptoms

A study from University Hospitals Connor Whole Health indicates that an insurance-supported integrative oncology program led to clinically meaningful improvements in cancer-related symptoms, including fatigue, nausea, depression, anxiety, stress, and pain. The research, recently published in JCO Oncology Practice, suggests the program offers a scalable model for incorporating integrative therapies into routine oncology care.

The research evaluated the first 16 months of the Connor Whole Health Integrative Oncology (CWHIO) Symptom Management Clinic. Between June 2023 and September 2024, the clinic provided 1,924 treatments to 291 patients. The patient group had a mean age of 60.8 years, and was 80.8% White and 73.2% female.

A Hybrid Financial Model

To address systemic barriers and limited insurance reimbursement, the CWHIO clinic utilized a hybrid billing model. While initial physician consultations and massage therapy are billed through insurance, group acupuncture is offered at a low self-pay rate of $36.85. Philanthropic support from the Elisabeth Severance Prentiss Foundation further assisted with non-billable services.

This approach seeks to reduce financial disparities, as many integrative oncology programs in the U.S. Rely heavily on out-of-pocket payments. The CWHIO clinic is embedded within the University Hospitals Seidman Cancer Center network and aligns its treatment plans with guidelines from the National Comprehensive Cancer Network and the American Society of Clinical Oncology.

According to Kristi Artz, MD, MS, FACLM, CCMS, Vice President of UH Connor Whole Health and Sara H. Connor Chair in Integrative Health, the study highlights strong patient interest in these services while underscoring persistent system-level barriers that continue to limit access.

Clinical Outcomes and Patient Response

The study found that single treatments resulted in significant reductions in moderate-to-severe symptoms. The mean reductions were as follows:

Patient satisfaction remained high throughout the program. Specifically, 87.1% of patients strongly agreed they were satisfied with the services, 85.5% strongly agreed they would refer others, and 82.3% strongly agreed the services supported effective symptom management. Demand for care grew over time, with weekly visits eventually peaking at 57 encounters following the introduction of individualized reiki and group acupuncture.

Jacob Wolf, ND, LAc, Dipl. OM, the Medical Director of Acupuncture at UH Connor Whole Health, stated:

"Integrative oncology bridges the best of conventional cancer treatment with evidence-based supportive therapies like acupuncture. This program demonstrates how acupuncture can help address symptom burden and improve quality of life when incorporated into comprehensive cancer care,"

Jacob Wolf, ND, LAc, Dipl. OM, via miragenews.com

Broadening the Integrative Approach

The shift toward "whole-person" care is also being pursued at other institutions. Gary Deng, director of the new Integrative Oncology Program at the UCI Health Chao Family Comprehensive Cancer Center, noted that cancer is now often a chronic disease. He argued that quality of life is as important as quantity of life in chronic disease management, stating that non-drug interventions and patient self-care can improve quality of life without increasing a patient's medication burden.

Further efforts to expand access to comprehensive cancer support are appearing in the insurance sector. Humana Inc. Recently announced a value-based care agreement with Thyme Care for eligible Medicare Advantage members in states including New Jersey, Pennsylvania, Tennessee, Indiana, Illinois, New York, and Michigan. This collaboration focuses on virtual care navigation, provider-led pharmacy interventions to reduce out-of-pocket costs, and data-driven insights for care teams.

The CWHIO study concludes that its insurance-based framework is potentially adaptable for effective, guideline-concordant symptom management. Future research on similar models is expected to further optimize patient satisfaction and accessibility.